299 related articles for article (PubMed ID: 15965110)
1. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow.
Gregory CA; Gunn WG; Reyes E; Smolarz AJ; Munoz J; Spees JL; Prockop DJ
Ann N Y Acad Sci; 2005 May; 1049():97-106. PubMed ID: 15965110
[TBL] [Abstract][Full Text] [Related]
2. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
Boland GM; Perkins G; Hall DJ; Tuan RS
J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/beta-catenin signaling pathway.
Zhang JF; Li G; Chan CY; Meng CL; Lin MC; Chen YC; He ML; Leung PC; Kung HF
Mol Cell Endocrinol; 2010 Jan; 314(1):70-4. PubMed ID: 19703516
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells.
van der Horst G; van der Werf SM; Farih-Sips H; van Bezooijen RL; Löwik CW; Karperien M
J Bone Miner Res; 2005 Oct; 20(10):1867-77. PubMed ID: 16160745
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Wnt signaling could promote bone marrow-derived mesenchymal stem cells to differentiate into hepatocytes.
Ke Z; Zhou F; Wang L; Chen S; Liu F; Fan X; Tang F; Liu D; Zhao G
Biochem Biophys Res Commun; 2008 Mar; 367(2):342-8. PubMed ID: 18174024
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets.
Giuliani N; Mangoni M; Rizzoli V
Exp Hematol; 2009 Aug; 37(8):879-86. PubMed ID: 19446662
[TBL] [Abstract][Full Text] [Related]
7. Dickkopf-1: a suitable target for the management of myeloma bone disease.
Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E
Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells.
de Boer J; Siddappa R; Gaspar C; van Apeldoorn A; Fodde R; van Blitterswijk C
Bone; 2004 May; 34(5):818-26. PubMed ID: 15121013
[TBL] [Abstract][Full Text] [Related]
9. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells.
Li HX; Luo X; Liu RX; Yang YJ; Yang GS
Mol Cell Endocrinol; 2008 Sep; 291(1-2):116-24. PubMed ID: 18584948
[TBL] [Abstract][Full Text] [Related]
10. Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow.
Gregory CA; Perry AS; Reyes E; Conley A; Gunn WG; Prockop DJ
J Biol Chem; 2005 Jan; 280(3):2309-23. PubMed ID: 15504735
[TBL] [Abstract][Full Text] [Related]
11. Role of Wnts in prostate cancer bone metastases.
Hall CL; Kang S; MacDougald OA; Keller ET
J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells.
Neth P; Ciccarella M; Egea V; Hoelters J; Jochum M; Ries C
Stem Cells; 2006 Aug; 24(8):1892-903. PubMed ID: 16690780
[TBL] [Abstract][Full Text] [Related]
13. Culture media conditioned by heat-shocked osteoblasts enhances the osteogenesis of bone marrow-derived mesenchymal stromal cells.
Ye CP; Heng BC; Liu H; Toh WS; Cao T
Cell Biochem Funct; 2007; 25(3):267-76. PubMed ID: 16927416
[TBL] [Abstract][Full Text] [Related]
14. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation.
Li X; Liu P; Liu W; Maye P; Zhang J; Zhang Y; Hurley M; Guo C; Boskey A; Sun L; Harris SE; Rowe DW; Ke HZ; Wu D
Nat Genet; 2005 Sep; 37(9):945-52. PubMed ID: 16056226
[TBL] [Abstract][Full Text] [Related]
15. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
16. WNT signaling pathway and stem cell signaling network.
Katoh M; Katoh M
Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling controls the fate of mesenchymal stem cells.
Ling L; Nurcombe V; Cool SM
Gene; 2009 Mar; 433(1-2):1-7. PubMed ID: 19135507
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell.
Sila-Asna M; Bunyaratvej A; Maeda S; Kitaguchi H; Bunyaratavej N
Kobe J Med Sci; 2007; 53(1-2):25-35. PubMed ID: 17579299
[TBL] [Abstract][Full Text] [Related]
19. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
[TBL] [Abstract][Full Text] [Related]
20. Role of growth hormone receptor signaling in osteogenesis from murine bone marrow progenitor cells.
Cool SM; Grünert M; Jackson R; Li H; Nurcombe V; Waters MJ
Biochem Biophys Res Commun; 2005 Dec; 338(2):1048-58. PubMed ID: 16259960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
